Peter Mourani
Concepts (469)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchopulmonary Dysplasia | 23 | 2021 | 70 | 6.330 |
Why?
| Hypertension, Pulmonary | 13 | 2023 | 124 | 3.800 |
Why?
| Intensive Care Units, Pediatric | 32 | 2024 | 174 | 3.670 |
Why?
| Heart Arrest | 19 | 2025 | 155 | 3.410 |
Why?
| Cardiopulmonary Resuscitation | 19 | 2025 | 139 | 3.270 |
Why?
| Respiration, Artificial | 20 | 2024 | 296 | 3.260 |
Why?
| Critical Illness | 25 | 2025 | 302 | 2.520 |
Why?
| Child | 100 | 2025 | 6910 | 2.510 |
Why?
| Prospective Studies | 51 | 2025 | 2378 | 2.330 |
Why?
| Pneumonia, Ventilator-Associated | 4 | 2025 | 20 | 2.160 |
Why?
| Infant, Premature | 17 | 2021 | 317 | 2.110 |
Why?
| Respiratory Tract Infections | 7 | 2024 | 78 | 2.010 |
Why?
| Shock, Septic | 12 | 2024 | 79 | 1.930 |
Why?
| Lung | 10 | 2024 | 504 | 1.800 |
Why?
| Sepsis | 12 | 2023 | 225 | 1.790 |
Why?
| Infant, Newborn | 45 | 2025 | 2749 | 1.760 |
Why?
| Respiratory Insufficiency | 6 | 2024 | 117 | 1.750 |
Why?
| Child, Preschool | 49 | 2025 | 3943 | 1.740 |
Why?
| Infant | 55 | 2025 | 3629 | 1.700 |
Why?
| Humans | 143 | 2025 | 50516 | 1.520 |
Why?
| Trachea | 3 | 2017 | 52 | 1.450 |
Why?
| Vascular Diseases | 5 | 2020 | 73 | 1.260 |
Why?
| Critical Care | 6 | 2021 | 214 | 1.200 |
Why?
| Influenza, Human | 9 | 2023 | 86 | 1.190 |
Why?
| Adolescent | 46 | 2025 | 6446 | 1.170 |
Why?
| Male | 72 | 2025 | 25913 | 1.140 |
Why?
| Quality of Life | 13 | 2024 | 852 | 1.140 |
Why?
| Female | 75 | 2025 | 27086 | 1.110 |
Why?
| Premature Birth | 4 | 2021 | 146 | 1.110 |
Why?
| Intensive Care Units | 10 | 2024 | 225 | 1.040 |
Why?
| Heart Ventricles | 2 | 2021 | 265 | 1.030 |
Why?
| Ventricular Dysfunction, Right | 3 | 2022 | 32 | 1.030 |
Why?
| Intubation, Intratracheal | 4 | 2024 | 119 | 1.010 |
Why?
| Bacteria | 6 | 2025 | 218 | 1.000 |
Why?
| Accelerometry | 1 | 2024 | 12 | 0.940 |
Why?
| Patient Discharge | 13 | 2024 | 321 | 0.930 |
Why?
| RNA, Ribosomal, 16S | 4 | 2021 | 112 | 0.900 |
Why?
| Echocardiography | 7 | 2021 | 400 | 0.880 |
Why?
| Noninvasive Ventilation | 1 | 2024 | 21 | 0.860 |
Why?
| Ventricular Function, Right | 2 | 2021 | 39 | 0.860 |
Why?
| Respiratory Syncytial Virus Infections | 3 | 2019 | 34 | 0.810 |
Why?
| Tobacco Smoke Pollution | 1 | 2023 | 48 | 0.800 |
Why?
| Risk Factors | 21 | 2024 | 3723 | 0.750 |
Why?
| Patient Readmission | 3 | 2024 | 227 | 0.700 |
Why?
| Exercise | 1 | 2024 | 516 | 0.690 |
Why?
| Aftercare | 5 | 2024 | 72 | 0.680 |
Why?
| Pulmonary Artery | 4 | 2024 | 154 | 0.670 |
Why?
| Epinephrine | 4 | 2024 | 97 | 0.660 |
Why?
| Retrospective Studies | 28 | 2025 | 6264 | 0.660 |
Why?
| Respiratory Tract Diseases | 1 | 2019 | 26 | 0.620 |
Why?
| Gestational Age | 7 | 2021 | 373 | 0.610 |
Why?
| Lung Diseases | 2 | 2010 | 94 | 0.590 |
Why?
| Nitric Oxide | 6 | 2022 | 259 | 0.590 |
Why?
| Echocardiography, Doppler | 3 | 2018 | 54 | 0.580 |
Why?
| Nutritional Support | 1 | 2017 | 35 | 0.580 |
Why?
| Child Nutritional Physiological Phenomena | 1 | 2017 | 33 | 0.580 |
Why?
| Metagenomics | 6 | 2025 | 42 | 0.570 |
Why?
| Proteomics | 5 | 2024 | 314 | 0.560 |
Why?
| Coinfection | 3 | 2022 | 41 | 0.550 |
Why?
| Energy Intake | 1 | 2017 | 176 | 0.540 |
Why?
| Respiratory Syncytial Viruses | 2 | 2013 | 12 | 0.530 |
Why?
| Oxygen | 4 | 2024 | 323 | 0.500 |
Why?
| Echocardiography, Doppler, Pulsed | 1 | 2015 | 9 | 0.490 |
Why?
| Energy Metabolism | 1 | 2017 | 286 | 0.490 |
Why?
| Myocardial Contraction | 1 | 2015 | 113 | 0.470 |
Why?
| Oxygen Inhalation Therapy | 1 | 2015 | 20 | 0.470 |
Why?
| Chlorides | 3 | 2020 | 49 | 0.470 |
Why?
| Pneumonia, Bacterial | 2 | 2025 | 28 | 0.470 |
Why?
| Practice Guidelines as Topic | 1 | 2017 | 468 | 0.460 |
Why?
| Venous Thromboembolism | 2 | 2012 | 74 | 0.450 |
Why?
| Paramyxoviridae Infections | 1 | 2013 | 3 | 0.450 |
Why?
| Metapneumovirus | 1 | 2013 | 5 | 0.450 |
Why?
| Ventricular Function, Left | 1 | 2015 | 169 | 0.440 |
Why?
| Infant, Extremely Low Birth Weight | 1 | 2014 | 27 | 0.440 |
Why?
| Natriuretic Peptide, Brain | 1 | 2014 | 29 | 0.440 |
Why?
| Acute Kidney Injury | 4 | 2021 | 303 | 0.440 |
Why?
| Pulmonary Embolism | 2 | 2012 | 99 | 0.430 |
Why?
| Caregivers | 4 | 2024 | 217 | 0.430 |
Why?
| Bacterial Infections | 3 | 2023 | 95 | 0.430 |
Why?
| Ventricular Dysfunction, Left | 2 | 2020 | 106 | 0.420 |
Why?
| Peripheral Vascular Diseases | 1 | 2013 | 21 | 0.420 |
Why?
| Cohort Studies | 13 | 2022 | 1452 | 0.420 |
Why?
| Quality Improvement | 3 | 2022 | 209 | 0.420 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2025 | 170 | 0.420 |
Why?
| Proteome | 2 | 2024 | 169 | 0.410 |
Why?
| Drug Resistance, Bacterial | 2 | 2025 | 72 | 0.390 |
Why?
| Logistic Models | 7 | 2024 | 899 | 0.390 |
Why?
| Cardiopulmonary Bypass | 2 | 2025 | 93 | 0.380 |
Why?
| Bereavement | 2 | 2021 | 13 | 0.380 |
Why?
| Denys-Drash Syndrome | 1 | 2011 | 3 | 0.380 |
Why?
| Influenza A virus | 3 | 2020 | 17 | 0.380 |
Why?
| Vasodilator Agents | 3 | 2021 | 100 | 0.370 |
Why?
| Embolectomy | 1 | 2011 | 13 | 0.370 |
Why?
| Wilms Tumor | 1 | 2011 | 18 | 0.370 |
Why?
| Research Design | 4 | 2022 | 353 | 0.360 |
Why?
| Pregnancy | 10 | 2024 | 2451 | 0.350 |
Why?
| Anti-Bacterial Agents | 5 | 2025 | 745 | 0.350 |
Why?
| Health Resources | 5 | 2024 | 74 | 0.350 |
Why?
| Milrinone | 2 | 2021 | 9 | 0.350 |
Why?
| Time Factors | 10 | 2024 | 2935 | 0.340 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 77 | 0.340 |
Why?
| Kidney Neoplasms | 1 | 2011 | 174 | 0.330 |
Why?
| Follow-Up Studies | 8 | 2021 | 2242 | 0.330 |
Why?
| Length of Stay | 5 | 2025 | 629 | 0.320 |
Why?
| Water-Electrolyte Imbalance | 2 | 2020 | 14 | 0.320 |
Why?
| Administration, Inhalation | 5 | 2022 | 112 | 0.310 |
Why?
| Phosphodiesterase Inhibitors | 1 | 2008 | 25 | 0.310 |
Why?
| Sulfones | 1 | 2008 | 24 | 0.310 |
Why?
| Multiple Organ Failure | 3 | 2023 | 48 | 0.310 |
Why?
| Coronary Care Units | 2 | 2018 | 8 | 0.310 |
Why?
| Infant, Extremely Premature | 2 | 2020 | 36 | 0.310 |
Why?
| Heart Diseases | 2 | 2023 | 213 | 0.300 |
Why?
| United States | 12 | 2024 | 4955 | 0.300 |
Why?
| Hernia, Diaphragmatic | 1 | 2008 | 22 | 0.290 |
Why?
| Longitudinal Studies | 4 | 2020 | 735 | 0.290 |
Why?
| Staphylococcal Infections | 2 | 2022 | 267 | 0.290 |
Why?
| Heparitin Sulfate | 2 | 2024 | 9 | 0.290 |
Why?
| Young Adult | 10 | 2024 | 4107 | 0.290 |
Why?
| Hospital Mortality | 8 | 2023 | 413 | 0.290 |
Why?
| Piperazines | 1 | 2008 | 119 | 0.290 |
Why?
| Staphylococcus | 2 | 2017 | 35 | 0.280 |
Why?
| Adult | 13 | 2024 | 13584 | 0.280 |
Why?
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 294 | 0.270 |
Why?
| Age Factors | 6 | 2021 | 1110 | 0.270 |
Why?
| Magnetic Resonance Imaging | 3 | 2025 | 1556 | 0.270 |
Why?
| Wounds and Injuries | 2 | 2021 | 287 | 0.270 |
Why?
| Parents | 4 | 2021 | 318 | 0.260 |
Why?
| Treatment Outcome | 11 | 2022 | 5285 | 0.250 |
Why?
| Pregnancy in Diabetics | 2 | 2024 | 26 | 0.250 |
Why?
| Muscle, Smooth, Vascular | 2 | 2004 | 131 | 0.250 |
Why?
| Feasibility Studies | 2 | 2024 | 391 | 0.240 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2025 | 11 | 0.240 |
Why?
| Bacteriological Techniques | 1 | 2025 | 41 | 0.240 |
Why?
| Diastole | 3 | 2019 | 70 | 0.230 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2024 | 41 | 0.230 |
Why?
| Viruses | 1 | 2024 | 22 | 0.230 |
Why?
| Heart Bypass, Right | 1 | 2024 | 15 | 0.230 |
Why?
| Hypercapnia | 1 | 2024 | 16 | 0.230 |
Why?
| Bradycardia | 1 | 2024 | 37 | 0.230 |
Why?
| Ribosomal Protein S6 | 1 | 2004 | 1 | 0.230 |
Why?
| Neuroimaging | 1 | 2025 | 87 | 0.230 |
Why?
| Arteriovenous Fistula | 1 | 2024 | 30 | 0.230 |
Why?
| Heart Failure | 2 | 2021 | 528 | 0.230 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2004 | 23 | 0.230 |
Why?
| Virus Diseases | 1 | 2024 | 42 | 0.230 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 17 | 0.220 |
Why?
| Employment | 1 | 2024 | 90 | 0.220 |
Why?
| Pulmonary Veins | 1 | 2024 | 41 | 0.220 |
Why?
| Blood Proteins | 1 | 2024 | 84 | 0.220 |
Why?
| Tunica Intima | 1 | 2004 | 55 | 0.220 |
Why?
| Receptors, Immunologic | 2 | 2022 | 35 | 0.220 |
Why?
| Skin Pigmentation | 1 | 2024 | 12 | 0.220 |
Why?
| Genetic Predisposition to Disease | 3 | 2019 | 510 | 0.220 |
Why?
| Fontan Procedure | 1 | 2024 | 70 | 0.220 |
Why?
| Myocytes, Smooth Muscle | 1 | 2004 | 87 | 0.220 |
Why?
| Respiration | 1 | 2024 | 99 | 0.220 |
Why?
| Protein Kinases | 1 | 2004 | 71 | 0.220 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 145 | 0.210 |
Why?
| Arteriovenous Malformations | 1 | 2024 | 76 | 0.210 |
Why?
| Oximetry | 1 | 2024 | 68 | 0.210 |
Why?
| Cotinine | 1 | 2023 | 21 | 0.210 |
Why?
| Smoke | 1 | 2023 | 18 | 0.210 |
Why?
| Colorado | 4 | 2017 | 21 | 0.210 |
Why?
| Hypotension | 1 | 2023 | 63 | 0.210 |
Why?
| Pneumonia, Staphylococcal | 1 | 2022 | 6 | 0.200 |
Why?
| Socioeconomic Factors | 3 | 2020 | 591 | 0.200 |
Why?
| Reproducibility of Results | 4 | 2020 | 1199 | 0.200 |
Why?
| Sodium | 1 | 2022 | 92 | 0.200 |
Why?
| Indoles | 1 | 2025 | 278 | 0.200 |
Why?
| Glasgow Coma Scale | 4 | 2023 | 46 | 0.200 |
Why?
| Hospitalization | 4 | 2023 | 675 | 0.200 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2022 | 6 | 0.200 |
Why?
| Meconium Aspiration Syndrome | 1 | 2022 | 2 | 0.200 |
Why?
| Computational Biology | 2 | 2025 | 215 | 0.200 |
Why?
| Sensitivity and Specificity | 4 | 2025 | 861 | 0.200 |
Why?
| Communicable Diseases | 1 | 2022 | 52 | 0.190 |
Why?
| Multivariate Analysis | 4 | 2018 | 583 | 0.190 |
Why?
| Shock | 1 | 2022 | 34 | 0.190 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 31 | 0.190 |
Why?
| Blood Pressure | 4 | 2023 | 531 | 0.190 |
Why?
| Central Venous Catheters | 1 | 2022 | 25 | 0.190 |
Why?
| Diabetes, Gestational | 1 | 2022 | 52 | 0.190 |
Why?
| Extremities | 1 | 2021 | 30 | 0.190 |
Why?
| Spinal Injuries | 1 | 2021 | 14 | 0.190 |
Why?
| Multiple Trauma | 1 | 2021 | 33 | 0.190 |
Why?
| Prone Position | 1 | 2021 | 31 | 0.190 |
Why?
| Iloprost | 1 | 2021 | 4 | 0.180 |
Why?
| Central Venous Pressure | 1 | 2021 | 7 | 0.180 |
Why?
| Abdominal Injuries | 1 | 2021 | 36 | 0.180 |
Why?
| Epoprostenol | 1 | 2021 | 24 | 0.180 |
Why?
| Pulmonary Circulation | 2 | 2015 | 34 | 0.180 |
Why?
| Patient Positioning | 1 | 2021 | 32 | 0.180 |
Why?
| Catheterization, Central Venous | 1 | 2022 | 85 | 0.180 |
Why?
| Thoracic Injuries | 1 | 2021 | 35 | 0.180 |
Why?
| Capnography | 1 | 2021 | 17 | 0.180 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 181 | 0.180 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2021 | 52 | 0.180 |
Why?
| Pneumonia | 1 | 2022 | 116 | 0.180 |
Why?
| Nervous System Diseases | 1 | 2022 | 89 | 0.180 |
Why?
| Radiography, Thoracic | 1 | 2021 | 65 | 0.180 |
Why?
| Vasopressins | 1 | 2021 | 39 | 0.180 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 55 | 0.180 |
Why?
| Chronic Disease | 3 | 2022 | 574 | 0.170 |
Why?
| Morbidity | 4 | 2022 | 130 | 0.170 |
Why?
| Angiogenic Proteins | 1 | 2020 | 6 | 0.170 |
Why?
| Medicine | 1 | 2020 | 56 | 0.170 |
Why?
| Cardiac Surgical Procedures | 1 | 2023 | 314 | 0.170 |
Why?
| Medical Audit | 1 | 2020 | 21 | 0.170 |
Why?
| Severity of Illness Index | 5 | 2020 | 978 | 0.170 |
Why?
| Incidence | 3 | 2024 | 1032 | 0.170 |
Why?
| Academic Medical Centers | 2 | 2017 | 149 | 0.170 |
Why?
| Hemodynamics | 3 | 2023 | 265 | 0.170 |
Why?
| Aged | 5 | 2024 | 9743 | 0.170 |
Why?
| Toll-Like Receptor 4 | 1 | 2020 | 52 | 0.160 |
Why?
| Medical Records | 1 | 2020 | 85 | 0.160 |
Why?
| Muscular Dystrophy, Duchenne | 1 | 2020 | 24 | 0.160 |
Why?
| Signal Transduction | 2 | 2020 | 1624 | 0.160 |
Why?
| Mannose-Binding Lectin | 1 | 2019 | 2 | 0.160 |
Why?
| Motivation | 1 | 2021 | 275 | 0.160 |
Why?
| Tertiary Care Centers | 1 | 2019 | 76 | 0.160 |
Why?
| Mothers | 2 | 2022 | 257 | 0.160 |
Why?
| Cardiotonic Agents | 1 | 2019 | 82 | 0.160 |
Why?
| Ultrasonography | 2 | 2025 | 435 | 0.150 |
Why?
| Hyperglycemia | 1 | 2019 | 81 | 0.150 |
Why?
| Fibroblasts | 1 | 2020 | 336 | 0.150 |
Why?
| MicroRNAs | 1 | 2022 | 344 | 0.150 |
Why?
| Mutation, Missense | 1 | 2019 | 103 | 0.150 |
Why?
| Respiratory System | 1 | 2018 | 27 | 0.150 |
Why?
| RNA, Bacterial | 2 | 2024 | 58 | 0.150 |
Why?
| Tomography, X-Ray Computed | 2 | 2025 | 1169 | 0.150 |
Why?
| Medical Staff, Hospital | 1 | 2018 | 15 | 0.150 |
Why?
| Inservice Training | 1 | 2018 | 32 | 0.150 |
Why?
| Adolescent Nutritional Physiological Phenomena | 1 | 2017 | 1 | 0.150 |
Why?
| Calorimetry, Indirect | 1 | 2017 | 25 | 0.150 |
Why?
| Chorioamnionitis | 1 | 2017 | 15 | 0.150 |
Why?
| Renal Replacement Therapy | 1 | 2018 | 30 | 0.140 |
Why?
| Survival Rate | 4 | 2024 | 909 | 0.140 |
Why?
| Risk Assessment | 5 | 2018 | 1269 | 0.140 |
Why?
| Physicians | 1 | 2021 | 232 | 0.140 |
Why?
| Drug Administration Schedule | 2 | 2024 | 370 | 0.140 |
Why?
| Fetal Membranes, Premature Rupture | 1 | 2017 | 22 | 0.140 |
Why?
| Metabolomics | 1 | 2018 | 135 | 0.140 |
Why?
| Intensive Care Units, Neonatal | 1 | 2018 | 124 | 0.140 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2018 | 326 | 0.140 |
Why?
| Hypoglycemic Agents | 1 | 2019 | 173 | 0.140 |
Why?
| Delirium | 1 | 2018 | 50 | 0.140 |
Why?
| Infant, Very Low Birth Weight | 1 | 2017 | 48 | 0.140 |
Why?
| Pre-Eclampsia | 1 | 2017 | 41 | 0.140 |
Why?
| Tandem Mass Spectrometry | 1 | 2018 | 238 | 0.140 |
Why?
| Heart Defects, Congenital | 2 | 2024 | 602 | 0.140 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2017 | 49 | 0.140 |
Why?
| Transcriptome | 3 | 2024 | 314 | 0.140 |
Why?
| Needs Assessment | 1 | 2017 | 136 | 0.140 |
Why?
| Smoking | 2 | 2018 | 507 | 0.140 |
Why?
| Observer Variation | 1 | 2017 | 139 | 0.140 |
Why?
| Hypertension | 2 | 2019 | 544 | 0.140 |
Why?
| Birth Weight | 1 | 2017 | 106 | 0.130 |
Why?
| Infant, Low Birth Weight | 2 | 2015 | 74 | 0.130 |
Why?
| RNA-Binding Proteins | 1 | 2017 | 118 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2019 | 169 | 0.130 |
Why?
| Patient Care Team | 1 | 2018 | 258 | 0.130 |
Why?
| Blood Glucose | 2 | 2019 | 447 | 0.130 |
Why?
| Delphi Technique | 3 | 2020 | 55 | 0.130 |
Why?
| Hospitals, Pediatric | 3 | 2023 | 235 | 0.130 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2021 | 383 | 0.130 |
Why?
| Endothelium-Dependent Relaxing Factors | 1 | 2015 | 4 | 0.130 |
Why?
| Organ Dysfunction Scores | 3 | 2020 | 18 | 0.130 |
Why?
| Trauma Centers | 3 | 2022 | 196 | 0.120 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2017 | 182 | 0.120 |
Why?
| Prognosis | 4 | 2023 | 1977 | 0.120 |
Why?
| Medical Informatics | 1 | 2016 | 54 | 0.120 |
Why?
| Indiana | 1 | 2015 | 14 | 0.120 |
Why?
| Membrane Proteins | 1 | 2017 | 332 | 0.120 |
Why?
| Hypokalemia | 1 | 2014 | 10 | 0.120 |
Why?
| Diabetic Ketoacidosis | 1 | 2014 | 18 | 0.120 |
Why?
| Viral Load | 2 | 2024 | 76 | 0.120 |
Why?
| Schools, Medical | 1 | 2015 | 70 | 0.110 |
Why?
| Hyperoxia | 2 | 2024 | 27 | 0.110 |
Why?
| Risk | 2 | 2012 | 324 | 0.110 |
Why?
| Bronchiolitis, Viral | 1 | 2013 | 7 | 0.110 |
Why?
| Influenza Vaccines | 1 | 2014 | 31 | 0.110 |
Why?
| Adaptive Immunity | 2 | 2024 | 32 | 0.110 |
Why?
| Carbon Dioxide | 2 | 2023 | 95 | 0.110 |
Why?
| Nasopharynx | 2 | 2023 | 25 | 0.100 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2012 | 10 | 0.100 |
Why?
| Cerebral Arterial Diseases | 1 | 2012 | 8 | 0.100 |
Why?
| Vitamin D | 1 | 2013 | 87 | 0.100 |
Why?
| Adrenal Cortex Hormones | 2 | 2024 | 99 | 0.100 |
Why?
| Anticoagulants | 2 | 2012 | 256 | 0.100 |
Why?
| Pediatrics | 1 | 2016 | 283 | 0.100 |
Why?
| Anti-Infective Agents | 1 | 2013 | 95 | 0.100 |
Why?
| Blood Coagulation Disorders | 1 | 2012 | 38 | 0.100 |
Why?
| Antiphospholipid Syndrome | 1 | 2012 | 10 | 0.100 |
Why?
| Antihypertensive Agents | 1 | 2013 | 125 | 0.100 |
Why?
| Enoxaparin | 1 | 2012 | 31 | 0.100 |
Why?
| Immunomodulation | 1 | 2012 | 36 | 0.100 |
Why?
| Polysaccharides | 1 | 2012 | 51 | 0.100 |
Why?
| Bacterial Load | 1 | 2011 | 12 | 0.100 |
Why?
| Interferons | 2 | 2022 | 38 | 0.100 |
Why?
| RNA, Ribosomal | 1 | 2011 | 19 | 0.100 |
Why?
| Abbreviated Injury Scale | 2 | 2021 | 6 | 0.100 |
Why?
| Fetal Blood | 1 | 2012 | 65 | 0.100 |
Why?
| Pressure | 2 | 2023 | 104 | 0.100 |
Why?
| Fibrinolytic Agents | 1 | 2012 | 125 | 0.100 |
Why?
| Suction | 1 | 2011 | 23 | 0.090 |
Why?
| Grief | 2 | 2021 | 9 | 0.090 |
Why?
| Fatal Outcome | 1 | 2012 | 197 | 0.090 |
Why?
| Postoperative Complications | 1 | 2018 | 1033 | 0.090 |
Why?
| Metagenome | 1 | 2011 | 40 | 0.090 |
Why?
| Survivors | 2 | 2022 | 127 | 0.090 |
Why?
| Stem Cells | 1 | 2012 | 166 | 0.090 |
Why?
| Phenotype | 2 | 2023 | 739 | 0.090 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2024 | 393 | 0.090 |
Why?
| Intensive Care, Neonatal | 1 | 2010 | 22 | 0.090 |
Why?
| Clinical Competence | 2 | 2023 | 398 | 0.080 |
Why?
| Stroke Volume | 2 | 2021 | 141 | 0.080 |
Why?
| Potassium | 2 | 2022 | 58 | 0.080 |
Why?
| Cytokines | 1 | 2012 | 606 | 0.080 |
Why?
| Gene Expression | 2 | 2022 | 610 | 0.080 |
Why?
| Purines | 1 | 2008 | 37 | 0.080 |
Why?
| Survival Analysis | 2 | 2022 | 661 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2023 | 572 | 0.070 |
Why?
| Diseases in Twins | 1 | 2008 | 14 | 0.070 |
Why?
| Pulmonary Wedge Pressure | 1 | 2008 | 26 | 0.070 |
Why?
| Pulmonary Edema | 1 | 2008 | 20 | 0.070 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2022 | 474 | 0.070 |
Why?
| Stroke | 1 | 2012 | 495 | 0.070 |
Why?
| Cardiovascular Diseases | 1 | 2012 | 460 | 0.070 |
Why?
| Neovascularization, Physiologic | 2 | 2012 | 68 | 0.070 |
Why?
| Cell Division | 2 | 2004 | 291 | 0.060 |
Why?
| Cardiac Catheterization | 1 | 2008 | 223 | 0.060 |
Why?
| Aorta | 2 | 2004 | 163 | 0.060 |
Why?
| Indoleacetic Acids | 1 | 2025 | 5 | 0.060 |
Why?
| RNA, Viral | 2 | 2017 | 107 | 0.060 |
Why?
| Angiopoietin-2 | 1 | 2024 | 15 | 0.060 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2024 | 39 | 0.060 |
Why?
| Animals | 5 | 2020 | 13124 | 0.060 |
Why?
| Hypocapnia | 1 | 2024 | 10 | 0.060 |
Why?
| Vascular Resistance | 1 | 2004 | 56 | 0.060 |
Why?
| Culture Media, Serum-Free | 1 | 2004 | 15 | 0.060 |
Why?
| Androstadienes | 1 | 2004 | 11 | 0.060 |
Why?
| Carotid Artery Injuries | 1 | 2004 | 13 | 0.060 |
Why?
| Respiratory Function Tests | 1 | 2004 | 86 | 0.060 |
Why?
| Diffuse Axonal Injury | 1 | 2023 | 2 | 0.060 |
Why?
| Chromones | 1 | 2004 | 18 | 0.060 |
Why?
| Oligonucleotides, Antisense | 1 | 2004 | 27 | 0.060 |
Why?
| Probability | 1 | 2004 | 164 | 0.060 |
Why?
| Middle Aged | 3 | 2024 | 12613 | 0.060 |
Why?
| Drug Resistance, Microbial | 1 | 2024 | 45 | 0.060 |
Why?
| PTEN Phosphohydrolase | 1 | 2004 | 53 | 0.060 |
Why?
| Glycocalyx | 1 | 2023 | 2 | 0.060 |
Why?
| Disaccharides | 1 | 2023 | 10 | 0.050 |
Why?
| Chondroitin Sulfates | 1 | 2023 | 13 | 0.050 |
Why?
| Immunity, Innate | 1 | 2024 | 105 | 0.050 |
Why?
| Corpus Callosum | 1 | 2023 | 28 | 0.050 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2004 | 78 | 0.050 |
Why?
| Morpholines | 1 | 2004 | 66 | 0.050 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 15 | 0.050 |
Why?
| Sirolimus | 1 | 2004 | 62 | 0.050 |
Why?
| Syndecan-1 | 1 | 2023 | 75 | 0.050 |
Why?
| Cost of Illness | 1 | 2024 | 114 | 0.050 |
Why?
| Water-Electrolyte Balance | 1 | 2023 | 20 | 0.050 |
Why?
| Catheterization | 1 | 2004 | 101 | 0.050 |
Why?
| Vasoconstrictor Agents | 1 | 2024 | 83 | 0.050 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 56 | 0.050 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 156 | 0.050 |
Why?
| Proteoglycans | 1 | 2023 | 83 | 0.050 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 140 | 0.050 |
Why?
| Sequence Analysis, RNA | 1 | 2023 | 89 | 0.050 |
Why?
| Chemotactic Factors | 1 | 2022 | 5 | 0.050 |
Why?
| Software | 1 | 2025 | 278 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2004 | 156 | 0.050 |
Why?
| Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| Rats, Sprague-Dawley | 2 | 2004 | 1585 | 0.050 |
Why?
| Sodium Bicarbonate | 1 | 2022 | 9 | 0.050 |
Why?
| Case-Control Studies | 2 | 2019 | 1155 | 0.050 |
Why?
| Phosphorylation | 1 | 2004 | 525 | 0.050 |
Why?
| Haemophilus influenzae | 1 | 2022 | 16 | 0.050 |
Why?
| Protein Kinase Inhibitors | 1 | 2004 | 204 | 0.050 |
Why?
| Hospitals | 1 | 2023 | 173 | 0.050 |
Why?
| Interferon-gamma | 1 | 2022 | 177 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 377 | 0.050 |
Why?
| Norepinephrine | 1 | 2022 | 114 | 0.050 |
Why?
| Complement Activation | 1 | 2021 | 24 | 0.050 |
Why?
| Patient Acuity | 1 | 2021 | 16 | 0.050 |
Why?
| Dopamine | 1 | 2022 | 175 | 0.050 |
Why?
| Injury Severity Score | 1 | 2021 | 164 | 0.050 |
Why?
| Influenza in Birds | 1 | 2020 | 1 | 0.050 |
Why?
| Birds | 1 | 2020 | 12 | 0.040 |
Why?
| Recurrence | 2 | 2012 | 659 | 0.040 |
Why?
| Calcium | 1 | 2022 | 398 | 0.040 |
Why?
| DNA, Bacterial | 1 | 2021 | 186 | 0.040 |
Why?
| Blood Gas Analysis | 1 | 2020 | 30 | 0.040 |
Why?
| Registries | 1 | 2023 | 563 | 0.040 |
Why?
| Seasons | 1 | 2020 | 79 | 0.040 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 342 | 0.040 |
Why?
| Stromal Cells | 1 | 2020 | 75 | 0.040 |
Why?
| Bicarbonates | 1 | 2020 | 17 | 0.040 |
Why?
| Cells, Cultured | 1 | 2004 | 1571 | 0.040 |
Why?
| Healthcare Disparities | 1 | 2024 | 281 | 0.040 |
Why?
| Endpoint Determination | 1 | 2020 | 26 | 0.040 |
Why?
| Single-Cell Analysis | 1 | 2020 | 63 | 0.040 |
Why?
| Rats | 2 | 2004 | 3292 | 0.040 |
Why?
| Regression Analysis | 1 | 2021 | 382 | 0.040 |
Why?
| American Heart Association | 1 | 2020 | 32 | 0.040 |
Why?
| Extracellular Matrix | 1 | 2020 | 109 | 0.040 |
Why?
| Pilot Projects | 1 | 2022 | 699 | 0.040 |
Why?
| Emergency Service, Hospital | 1 | 2024 | 484 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2021 | 120 | 0.040 |
Why?
| Community-Acquired Infections | 1 | 2020 | 39 | 0.040 |
Why?
| Interferon-alpha | 1 | 2020 | 47 | 0.040 |
Why?
| Hematoma, Subdural | 1 | 2019 | 21 | 0.040 |
Why?
| Bayes Theorem | 1 | 2020 | 107 | 0.040 |
Why?
| Consensus | 1 | 2020 | 160 | 0.040 |
Why?
| Skull Fractures | 1 | 2019 | 17 | 0.040 |
Why?
| Maternal Exposure | 2 | 2012 | 96 | 0.040 |
Why?
| Cardiac Output | 1 | 2019 | 44 | 0.040 |
Why?
| Data Collection | 1 | 2020 | 280 | 0.040 |
Why?
| Guidelines as Topic | 1 | 2020 | 109 | 0.040 |
Why?
| Mortality | 1 | 2020 | 96 | 0.040 |
Why?
| Intracranial Hemorrhages | 1 | 2019 | 38 | 0.040 |
Why?
| Amino Acid Substitution | 1 | 2019 | 81 | 0.040 |
Why?
| RNA, Messenger | 1 | 2022 | 1089 | 0.040 |
Why?
| Family | 1 | 2020 | 178 | 0.040 |
Why?
| Staphylococcus aureus | 1 | 2022 | 321 | 0.040 |
Why?
| Creatinine | 1 | 2019 | 145 | 0.040 |
Why?
| Inflammation | 1 | 2023 | 610 | 0.040 |
Why?
| Communication | 1 | 2021 | 250 | 0.040 |
Why?
| Gene Expression Profiling | 2 | 2020 | 1025 | 0.040 |
Why?
| Metabolic Clearance Rate | 1 | 2019 | 69 | 0.040 |
Why?
| Adaptation, Psychological | 1 | 2020 | 227 | 0.040 |
Why?
| Antiviral Agents | 1 | 2020 | 170 | 0.040 |
Why?
| Multicenter Studies as Topic | 1 | 2018 | 89 | 0.040 |
Why?
| Comorbidity | 1 | 2020 | 623 | 0.040 |
Why?
| Glucocorticoids | 1 | 2020 | 230 | 0.040 |
Why?
| Proteins | 1 | 2000 | 339 | 0.040 |
Why?
| Pandemics | 1 | 2022 | 562 | 0.040 |
Why?
| Point-of-Care Systems | 1 | 2018 | 57 | 0.040 |
Why?
| Causality | 1 | 2017 | 47 | 0.040 |
Why?
| Genotyping Techniques | 1 | 2017 | 20 | 0.040 |
Why?
| Diagnosis, Differential | 1 | 2021 | 1033 | 0.040 |
Why?
| Homozygote | 1 | 2017 | 56 | 0.040 |
Why?
| Social Class | 1 | 2018 | 94 | 0.040 |
Why?
| Linear Models | 1 | 2018 | 279 | 0.030 |
Why?
| Protein Isoforms | 1 | 2017 | 116 | 0.030 |
Why?
| Protein Binding | 1 | 2019 | 654 | 0.030 |
Why?
| Body Weight | 1 | 2019 | 517 | 0.030 |
Why?
| Depression | 1 | 2021 | 582 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2018 | 930 | 0.030 |
Why?
| National Institutes of Health (U.S.) | 1 | 2016 | 44 | 0.030 |
Why?
| Models, Biological | 1 | 2019 | 716 | 0.030 |
Why?
| Algorithms | 1 | 2019 | 628 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2018 | 573 | 0.030 |
Why?
| Child Health Services | 1 | 2016 | 78 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 674 | 0.030 |
Why?
| Orthomyxoviridae | 1 | 2014 | 3 | 0.030 |
Why?
| Immune System | 1 | 2013 | 43 | 0.030 |
Why?
| Vitamin D Deficiency | 1 | 2013 | 44 | 0.030 |
Why?
| Disease Progression | 1 | 2015 | 829 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2014 | 199 | 0.020 |
Why?
| Leukocytes, Mononuclear | 1 | 2012 | 118 | 0.020 |
Why?
| Diagnostic Imaging | 1 | 2012 | 181 | 0.020 |
Why?
| Electrocardiography | 1 | 2012 | 263 | 0.020 |
Why?
| Mice | 1 | 2020 | 5687 | 0.020 |
Why?
| Endothelial Cells | 1 | 2012 | 258 | 0.020 |
Why?
| Dietary Supplements | 1 | 2013 | 449 | 0.020 |
Why?
| Flow Cytometry | 1 | 2012 | 474 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2000 | 64 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2000 | 190 | 0.010 |
Why?
|
|
Mourani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|